9,292 Shares in Celldex Therapeutics, Inc. (NASDAQ:CLDX) Purchased by Hsbc Holdings PLC
Hsbc Holdings PLC purchased a new stake in Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) in the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 9,292 shares of the biopharmaceutical company’s stock, valued at approximately $233,000. Several other hedge funds have also bought and sold shares of the stock. Vanguard Group Inc. increased its […]
Hsbc Holdings PLC purchased a new stake in Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) in the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 9,292 shares of the biopharmaceutical company’s stock, valued at approximately $233,000. Several other hedge funds have also bought and sold shares of the stock. Vanguard Group Inc. increased its […]
